関連する実験動画

Updated: May 7, 2026

Specific and Accurate Detection of the Citrus Greening Pathogen Candidatus liberibacter spp. Using Conventional PCR on Citrus Leaf Tissue Samples

Specific and Accurate Detection of the Citrus Greening Pathogen Candidatus liberibacter spp. Using Conventional PCR on Citrus Leaf Tissue Samples

Published on: June 29, 2018

ターゲットを絞ったMYC2の安定化により,類はHuanglongbing耐性を獲得する

Pingzhi Zhao^1,2, Huan Yang^1,2, Yanwei Sun¹

¹State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Science (New York, N.Y.)

|April 10, 2025

まとめ

研究者らは,PUB21とMYC2を含む,類病に対する耐性回路を特定した. ペプチドはMYC2を安定させ,植物とフィールド試験でHuanglongbing (HLB) 耐性を授与した.

科学分野:

植物病理学
分子生物学
遺伝学

背景:

フアンロンビング (HLB) は,効果的な治療法のない重症な類病です.
ジャスモネート媒介の防御経路は植物免疫に不可欠です
レジスタンスメカニズムを理解することはリンゴ作物の保護に不可欠です

研究の目的:

リンゴのHLB耐性の基礎にある分子メカニズムを解明する.
HLB対策の新たな目標と戦略を特定する.
HLBのペプチドベースの治療法を開発する.

主な方法:

E3ユビキチンリガゼPUB21とMYC2転写因子を含む制御回路を調査した.
遺伝子調節とタンパク質の安定性に対するヘリトロン挿入効果を分析した.
抗タンパク質分解ペプチド (APP) を識別するために人工知能を利用した.
温室とフィールド試験を含むHLB耐性アッセイでテストされたペプチドの有効性.

主要な成果:

ジャスモネート介護防御を制御するPUB21とMYC2を含むの調節回路が特定されました.
ヘリトロン挿入は,PUB21の活性とMYC2の分解の間のリンクを生み出しました.
PUB21のパラログの産外発現はMYC2を安定させ,HLBに対する耐性を授与した.
AIで特定されたAPP,特にAPP3-14はPUB21を阻害し,MYC2を安定させ,HLBを制御した.

結論:

PUB21媒介によるMYC2調節を中心とした新しいHLB耐性メカニズムが発見されました.
抗タンパク質溶解ペプチドは,抵抗性タンパク質を安定させ,HLBと戦うための有望な戦略です.
このアプローチは培養不可能な病原体によって引き起こされる病気の管理に新しい道を開きます

さらに関連する動画

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

Automating Citrus Budwood Processing for Downstream Pathogen Detection Through Instrument Engineering

Automating Citrus Budwood Processing for Downstream Pathogen Detection Through Instrument Engineering

Published on: April 21, 2023

関連する概念動画

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...